Status:
COMPLETED
Evaluation of Target Organs Impairment on Patients Suffering From High Blood Pressure
Lead Sponsor:
AstraZeneca
Conditions:
Blood Pressure
Eligibility:
All Genders
18+ years
Brief Summary
Evaluation of target organs impairment on patients suffering from high blood pressure without known cardio vascular or renal disease, stratified on blood pressure control.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Adults with hypertension (treated or not), without known cardiovascular or renal disease.
Exclusion
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT00925470
Start Date
June 1 2009
End Date
December 1 2009
Last Update
December 18 2009
Active Locations (369)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Abbeville, France
2
Research Site
Aire-sur-l'Adour, France
3
Research Site
Aix-en-Provence, France
4
Research Site
Ajaccio, France